Paul Tudor Jones's CRL Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 0 shares of Charles River Laboratories International, Inc. (CRL) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in CRL, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2016, adding 244,223 shares. Largest reduction occurred in Q3 2016, reducing 153,937 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
Paul Tudor Jones's Charles River Laboratories International Investment FAQs
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 92,717 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $14.51 M.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Charles River Laboratories International, Inc. (CRL) was 264,559 shares, as reported at the end of Q1 2016.